FindTrial
Sign In

A novel intelligent chromo capsule endoscope for the diagnosis of neoplastic lesions in the gastrointestinal tract

A novel intelligent chromo capsule endoscope for the diagnosis of neoplastic lesions in the gastrointestinal tract: A single-center, prospective in vitro study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058461
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-04-11
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal cancer

Interventions

Gold Standard:Pathological diagnosis is the gold standard
Index test:Imaging effects of narrow-band imaging mode and ordinary white light mode of a new intelligent dyeing capsule endoscope

Sponsors

Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who need to undergo endoscopic treatment and obtain gastrointestinal specimens; 2. Voluntarily join the experiment and sign the written informed consent.

Exclusion criteria

Exclusion criteria: The patient refuses or has no legal capacity, and the continuation of the research is affected by medical or ethical reasons.

Design outcomes

Primary

MeasureTime frame
Image clarity;Receiver Operating Characteristic Curve index;—

Countries

China

Contacts

Public ContactRong Lin

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

selinalin35@hotmail.com+86 15629180035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026